Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| NPT2A | Q06495 | Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1) | Disease related genesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 8 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| NPT2B | O95436 | Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) | Cancer-related genesDisease related genesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted membrane proteinsTransporters | 8 | Lung cancerOvarian cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| NSMA | O60906 | Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase) (nSMase1) | EnzymesMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 2 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NTAL | Q9GZY6 | Linker for activation of T-cells family member 2 (Linker for activation of B-cells) (Membrane-associated adapter molecule) (Non-T-cell activation linker) (Williams-Beuren syndrome chromosomal region 15 protein) (Williams-Beuren syndrome chromosomal region 5 protein) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NTCP5 | Q5PT55 | Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5) | Predicted membrane proteinsTransporters | 9 | Fusion and delivery mediation | 1 | 0.50 | |||
| NTNG1 | Q9Y2I2 | Netrin-G1 (Laminet-1) | Adhesion and uptake mediationMetabolism mediation | 1 | 0.50 | |||||
| O13C9 | Q8NGT0 | Olfactory receptor 13C9 (Olfactory receptor OR9-13) | 7 | Other mediation | 1 | 0.50 | ||||
| OBSCN | Q5VST9 | Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) | Disease related genesEnzymesPlasma proteinsPotential drug targetsPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| OLR1 | P78380 | Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form] | 1 | Arterial occlusive diseaseCardiovascular diseaseCoronary atherosclerosis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| OR2C3 | Q8N628 | Olfactory receptor 2C3 (Olfactory receptor 2C4) (Olfactory receptor 2C5) (Olfactory receptor OR1-30) | 7 | Other mediation | 1 | 0.50 | ||||
| OR6B3 | Q8NGW1 | Olfactory receptor 6B3 (Olfactory receptor OR2-2) | G-protein coupled receptorsPredicted membrane proteins | 7 | Other mediation | 1 | 0.50 | |||
| OX2R | O43614 | Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | DepressionInsomniaNarcolepsy | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| P | Q04671 | P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog) | 12 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| P2RX5 | Q93086 | P2X purinoceptor 5 (P2X5) (ATP receptor) (Purinergic receptor) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 2 | Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| PALM | O75781 | Paralemmin-1 (Paralemmin) | Predicted intracellular proteins | Receptor-signaling mediation | 1 | 0.50 | ||||
| PALS1 | Q8N3R9 | Protein PALS1 (MAGUK p55 subfamily member 5) (Membrane protein, palmitoylated 5) (Protein associated with Lin-7 1) | Plasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PANX2 | Q96RD6 | Pannexin-2 | Predicted membrane proteinsTransporters | 4 | Immune mediation | 1 | 0.50 | |||
| PAQR8 | Q8TEZ7 | Membrane progestin receptor beta (mPR beta) (Lysosomal membrane protein in brain 1) (Membrane progesterone P4 receptor beta) (Membrane progesterone receptor beta) (Progesterone and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII) | 7 | Other mediation | 1 | 0.50 | ||||
| PC11X | Q9BZA7 | Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.50 | |||
| PC11Y | Q9BZA8 | Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22) | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PCD16 | Q96JQ0 | Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1) | Disease related genesHuman disease related genesPlasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.50 | |||
| PCD23 | Q6V1P9 | Protocadherin-23 (Cadherin-27) (Cadherin-like protein CDHJ) (Cadherin-like protein VR8) (Protein dachsous homolog 2) (Protocadherin PCDHJ) | Predicted intracellular proteinsPredicted membrane proteins | 2 | Adhesion and uptake mediation | 1 | 0.50 | |||
| PCDA4 | Q9UN74 | Protocadherin alpha-4 (PCDH-alpha-4) | Predicted membrane proteins | 1 | Adhesion and uptake mediationClinical-translation mediation | 1 | 0.50 | |||
| PCDA5 | Q9Y5H7 | Protocadherin alpha-5 (PCDH-alpha-5) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.50 | |||
| PCDAC | Q9UN75 | Protocadherin alpha-12 (PCDH-alpha-12) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.50 |